Assessment methods for angiogenesis and current approaches for its quantification

被引:19
作者
AlMalki, Waleed Hassan [1 ,2 ]
Shahid, Imran [1 ,2 ]
Mehdi, Abeer Yousaf [1 ,2 ]
Hafeez, Muhammad Hassan [3 ]
机构
[1] Umm Al Qura Univ, Coll Pharm, Dept Pharmacol, Mecca, Saudi Arabia
[2] Umm Al Qura Univ, Coll Pharm, Dept Toxicol, Mecca, Saudi Arabia
[3] Fatima Mem Hosp & Med Coll, Lahore, Pakistan
关键词
Angiogenesis; angiogenesis assays; quantification techniques; GROWTH; INHIBITION;
D O I
10.4103/0253-7613.132152
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Angiogenesis is a physiological process which describes the development of new blood vessels from the existing vessels. It is a common and the most important process in the formation and development of blood vessels, so it is supportive in the healing of wounds and granulation of tissues. The different assays for the evaluation of angiogenesis have been described with distinct advantages and some limitations. In order to develop angiogenic and antiangiogenic techniques, continuous efforts have been resulted to give animal models for more quantitative analysis of angiogenesis. Most of the studies on angiogenic inducers and inhibitors rely on various models, both in vitro, in vivo and in ova, as indicators of efficacy. The angiogenesis assays are very much helpful to test efficacy of both pro-and anti-angiogenic agents. The development of non-invasive procedures for quantification of angiogenesis will facilitate this process significantly. The main objective of this review article is to focus on the novel and existing methods of angiogenesis and their quantification techniques. These findings will be helpful to establish the most convenient methods for the detection, quantification of angiogenesis and to develop a novel, well tolerated and cost effective anti-angiogenic treatment in the near future.
引用
收藏
页码:251 / 256
页数:6
相关论文
共 45 条
[1]   GROWTH-REGULATION OF THE VASCULAR SYSTEM - EVIDENCE FOR A METABOLIC HYPOTHESIS [J].
ADAIR, TH ;
GAY, WJ ;
MONTANI, JP .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (03) :R393-R404
[2]  
[Anonymous], AM J PHYSL REGULAT R
[3]  
Auerbach R, 1996, IBC BIOMEDICAL LIB S, P131
[4]   Angiotensinogen and its cleaved derivatives inhibit angiogenesis [J].
Célérier, J ;
Cruz, A ;
Lamandé, N ;
Gase, JM ;
Corvol, P .
HYPERTENSION, 2002, 39 (02) :224-228
[5]  
Chaddarling E, 2005, AM J PHYSIOL-HEART C, V289, P1618
[6]   Bevacizumab for the Treatment of Recurrent Glioblastoma [J].
Chamberlain, Marc C. .
CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2011, 5 :117-129
[7]  
Chien CC, 2011, BIOTECHNOL ADV, V8, P52
[8]   Inhibition of angiogenesis by the antifungal drug itraconazole [J].
Chong, Curtis R. ;
Xu, Jing ;
Lu, Jun ;
Bhat, Shridhar ;
Sullivan, David J., Jr. ;
Liu, Jun O. .
ACS CHEMICAL BIOLOGY, 2007, 2 (04) :263-270
[9]  
Christ PC., 2001, J IMMUNOL, V167, P1644
[10]   A new nerve growth factor-mimetic peptide active on neuropathic pain in rats [J].
Colangelo, Anna Maria ;
Bianco, Maria Rosaria ;
Vitagliano, Luigi ;
Cavaliere, Carlo ;
Cirillo, Giovanni ;
De Gioia, Luca ;
Diana, Donatella ;
Colombo, Daniele ;
Redaelli, Cristina ;
Zaccaro, Laura ;
Morelli, Giancarlo ;
Papa, Michele ;
Sarmientos, Paolo ;
Alberghina, Lilia ;
Martegani, Enzo .
JOURNAL OF NEUROSCIENCE, 2008, 28 (11) :2698-2709